%0 Journal Article
%T Cholangiocarcinoma: Epidemiology and Imaging-Based Review.
%A Kidanemariam S
%A Gu J
%A Yoon JH
%A Challapalli JV
%A Fruh V
%A Sax AJ
%J R I Med J (2013)
%V 107
%N 5
%D 2024 May 2
%M 38687269
暂无%X Cholangiocarcinoma (CCA) is a rare cancer of the bile duct epithelium, and in the last few decades its incidence rate has been increasing. It is associated with a high mortality rate due to late diagnosis and its aggressive nature. Many risk factors have been identified; some are more common in certain regions than others. CCA can be classified according to its anatomical location or macroscopic growth pattern, the latter being most helpful for imaging interpretation. Clinical features can vary from obstructive-like symptoms to nonspecific symptoms, such as weight loss and malaise. Imaging, specifically MRI/MRCP, is crucial in diagnosing CCA, staging, and treatment planning. Surgery with chemotherapy is the mainstay treatment option, and other palliative treatment options exist for those who have unresectable disease.